CAPTRUST Financial Advisors
CASI icon

CAPTRUST Financial Advisors’s CASI Pharmaceuticals CASI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-150
Closed – – 2367
2022
Q2 		$0 Hold
150
– – ﹤0.01% 4945
2022
Q1 		$1K Hold
150
– – ﹤0.01% 4661
2021
Q4 		$1K Hold
150
– – ﹤0.01% 4543
2021
Q3 		$2K Hold
150
– – ﹤0.01% 4238
2021
Q2 		$2K Hold
150
– – ﹤0.01% 4152
2021
Q1 		$4K Hold
150
– – ﹤0.01% 3796
2020
Q4 		$4K Hold
150
– – ﹤0.01% 2895
2020
Q3 		$2K Hold
150
– – ﹤0.01% 2744
2020
Q2 		$4K Buy
+150
New +$3.26K ﹤0.01% 2429

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAPTRUST Financial Advisors's CASI Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of CASI Pharmaceuticals (CASI) in Q3 2022, closing a stake of 150 shares.

CAPTRUST Financial Advisors first reported a position in CASI in Q2 2020 and held it in 9 quarters. The position peaked at $4K in Q1 2021. 24 funds tracked by Wall St. Rank hold CASI as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining CASI Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 150 CASI Pharmaceuticals shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in CASI Pharmaceuticals in Q2 2020 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's CASI Pharmaceuticals position peaked at $4K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.